Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Type 2 Diabetes Mellitus - Poor Control”

46 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 46 results

Not applicableStudy completedNCT06385899
What this trial is testing

Effect of Intensive Monitoring of Patients With Poorly Controlled Type 2 Diabetes With Different Glycemic Background

Who this might be right for
Type 2 DiabetesPoor Glycemic Control
Goztepe Prof Dr Suleyman Yalcın City Hospital 266
Testing effectiveness (Phase 2)Study completedNCT04466904
What this trial is testing

Multiple-dose Tolerability and Pharmacokinetic of IBI362 in Chinese Patients With T2DM

Who this might be right for
Type 2 Diabetes
Innovent Biologics (Suzhou) Co. Ltd. 42
Not applicableStudy completedNCT04438018
What this trial is testing

Towards a Better Understanding of Diabetes Distress, Depression and Poor Glycaemic Control in T2DM

Who this might be right for
Diabetes Mellitus, Type 2Depressive SymptomsStress, Psychological+1 more
Norbert Hermanns 205
Not applicableStudy completedNCT04667728
What this trial is testing

Professional Continuous Glucose Monitoring as an Adjuvant Educational Tool for Improving Glycemic Control in Patients With Type 2 Diabetes.

Who this might be right for
Diabetes Mellitus, Type 2
Instituto de Seguridad y Servicios Sociales de los Trabajadores del Estado 302
Large-scale testing (Phase 3)Active Not RecruitingNCT06777238
What this trial is testing

A Phase III Clinical Study to Evaluate the Efficacy and Safety of GZR18 Injection in Subjects With Type 2 Diabetes Mellitus and Poor Blood Glucose Control by Diet and Exercise

Who this might be right for
Type 2 Diabetes Mellitus (T2DM)
Gan & Lee Pharmaceuticals. 274
Large-scale testing (Phase 3)Active Not RecruitingNCT06778967
What this trial is testing

A Phase III Clinical Study to Evaluate the Efficacy and Safety of GZR18 Injection in Adult Type 2 Diabetes Mellitus

Who this might be right for
Type 2 Diabetes Mellitus (T2DM)
Gan & Lee Pharmaceuticals. 1,100
Large-scale testing (Phase 3)UnknownNCT05326490
What this trial is testing

Study to Evaluate the Efficacy and Safety of PB-201 in Type 2 Diabetic Mellitus Patients With Poor Glycemic Control Via Metformin Hydrochloride Monotherapy

Who this might be right for
Type 2 Diabetes Mellitus
PegBio Co., Ltd. 546
Large-scale testing (Phase 3)Active Not RecruitingNCT06649773
What this trial is testing

The Experiment of Noiiglutide Injection in Type 2 Diabetes Patients

Who this might be right for
Type 2 Diabetes
Jiangsu HengRui Medicine Co., Ltd. 137
Large-scale testing (Phase 3)UnknownNCT06339086
What this trial is testing

Efficacy and Safety of Semaglutide Injection in Subjects With Type 2 Diabetes

Who this might be right for
Type 2 Diabetes Mellitus
Chengdu Brilliant Pharmaceutical Co., Ltd. 478
Not applicableStudy completedNCT01688778
What this trial is testing

Telemedicine as a Means to Achieving Good Diabetes Control Among Patients With Type 2 Diabetes

Who this might be right for
Type 2 DiabetesPoor Glycemic ControlMedication Adherence
Bispebjerg Hospital 165
Not applicableStudy completedNCT02456064
What this trial is testing

Impact of a Program of Non-pharmacological Intervention in Patients With Type 2 Diabetes Mellitus

Who this might be right for
Diabetes Mellitus, Type 2
Equipo Multidisciplinar Sanitario CS Foietes 25
Large-scale testing (Phase 3)Study completedNCT00468039
What this trial is testing

A Sub-study to LMF237A2302 to Assess the Effect of 24 Weeks Treatment With Initial Combination of Vildagliptin Plus Metformin

Who this might be right for
Diabetes Mellitus, Type 2
Novartis 94
Post-approval studies (Phase 4)Study completedNCT02049814
What this trial is testing

Efficacy and Safety of Voglibose Compared With Acarbose in Participants With Type 2 Diabetes

Who this might be right for
Type 2 Diabetes Mellitus
Takeda 494
Not applicableStudy completedNCT01307566
What this trial is testing

Evolution With CPAP Treatment of a Cohort of Type 2 Diabetic Patients With Apnea-hypopnea Syndrome

Who this might be right for
Sleep ApneaType 2 Diabetes
Hospital de Granollers 50
Large-scale testing (Phase 3)UnknownNCT05318326
What this trial is testing

A Randomized, Double-blind, Placebo-controlled, Multicenter Clinical Trial to Evaluate the Clinical Efficacy and Safety of Yogliptin Tablets

Who this might be right for
Type 2 Diabetes
Chengdu Easton Biopharmaceuticals Co,Ltd 450
Not applicableUnknownNCT06007014
What this trial is testing

Efficacy and Safety of Chiglitazar Added to Glargine in Patients With Type 2 Diabetes

Who this might be right for
Efficacy and Safety of Chiglitazar Sodium in the Treatment of T2DM PatientsMetformin Combined With Insulin Glargine in the Treatment of Type 2 Diabetes Patients Who Still Have Poor Hypoglycemic Effect128 Patients Were Randomly Assigned 1:1+4 more
Yanbing Li 128
Testing effectiveness (Phase 2)UnknownNCT02917928
What this trial is testing

The Potential of Carnosine Supplementation in Optimising Cardiometabolic Health

Who this might be right for
Poor Glycemic ControlCardiovascular Risk FactorsCognitive Function 1, Social
Monash University 40
Not applicableUnknownNCT03805191
What this trial is testing

Sufficient Acarbose Decreased Glucose Excursion in Type 2 Diabetic Patients

Who this might be right for
Type 2 Diabetes MellitusPoor Glycemic Control
Qilu Hospital of Shandong University 900
Not applicableLooking for participantsNCT07054125
What this trial is testing

Continuous Glucose Monitoring, Diabetes Education, and Peer Support for Management of Uncontrolled Type 2 Diabetes

Who this might be right for
Type 2 Diabetes Mellitus - Poor Control
Whole Endo 100
Testing effectiveness (Phase 2)Study completedNCT06849843
What this trial is testing

3mg Once Every Two Weeks Administration of Efsubaglutide Alfa Injection in Type 2 Diabetes Patients.

Who this might be right for
Type2 Diabetes
Shanghai Yinnuo Pharmaceutical Technology Co., Ltd. 59
Load More Results